From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 07 2019
Historique:
received: 17 07 2018
revised: 14 09 2018
accepted: 19 09 2018
pubmed: 12 10 2018
medline: 2 11 2019
entrez: 11 10 2018
Statut: ppublish

Résumé

Colorectal cancer (CRC) is one of the most common cancers in Latin America and the Caribbean, with the highest rates reported for Uruguay, Brazil and Argentina. We provide a global snapshot of the CRC patterns, how screening is performed, and compared/contrasted to the genetic profile of Lynch syndrome (LS) in the region. From the literature, we find that only nine (20%) of the Latin America and the Caribbean countries have developed guidelines for early detection of CRC, and also with a low adherence. We describe a genetic profile of LS, including a total of 2,685 suspected families, where confirmed LS ranged from 8% in Uruguay and Argentina to 60% in Peru. Among confirmed LS, path_MLH1 variants were most commonly identified in Peru (82%), Mexico (80%), Chile (60%), and path_MSH2/EPCAM variants were most frequently identified in Colombia (80%) and Argentina (47%). Path_MSH6 and path_PMS2 variants were less common, but they showed important presence in Brazil (15%) and Chile (10%), respectively. Important differences exist at identifying LS families in Latin American countries, where the spectrum of path_MLH1 and path_MSH2 variants are those most frequently identified. Our findings have an impact on the evaluation of the patients and their relatives at risk for LS, derived from the gene affected. Although the awareness of hereditary cancer and genetic testing has improved in the last decade, it is remains deficient, with 39%-80% of the families not being identified for LS among those who actually met both the clinical criteria for LS and showed MMR deficiency.

Identifiants

pubmed: 30303536
doi: 10.1002/ijc.31920
pmc: PMC6587543
doi:

Substances chimiques

MLH1 protein, human 0
MSH2 protein, human EC 3.6.1.3
MutL Protein Homolog 1 EC 3.6.1.3
MutS Homolog 2 Protein EC 3.6.1.3

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-326

Informations de copyright

© 2018 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Rev Gastroenterol Peru. 2016 Jan-Mar;36(1):35-42
pubmed: 27131939
Genet Mol Biol. 2016 May 24;39(2):166-7
pubmed: 27223489
Fam Cancer. 2016 Jul;15(3):437-45
pubmed: 27007491
Cancer. 2018 Aug 1;124(15):3145-3153
pubmed: 29750335
Curr Opin Gastroenterol. 2010 Sep;26(5):466-70
pubmed: 20664346
Ann Glob Health. 2014 Sep-Oct;80(5):370-7
pubmed: 25512152
Lancet Oncol. 2013 Apr;14(5):391-436
pubmed: 23628188
Ann Glob Health. 2014 Sep-Oct;80(5):412-7
pubmed: 25512156
Fam Cancer. 2013 Jun;12(2):175-80
pubmed: 23443670
Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Gastroenterology. 2008 May;134(5):1570-95
pubmed: 18384785
Fam Cancer. 2011 Dec;10(4):641-7
pubmed: 21681552
Rev Invest Clin. 2017 Mar-Apr;69(2):94-102
pubmed: 28453507
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Genes Chromosomes Cancer. 2018 Jul;57(7):350-358
pubmed: 29520894
Genet Mol Biol. 2014 Mar;37(1 Suppl):234-40
pubmed: 24764757
Front Oncol. 2016 Aug 24;6:189
pubmed: 27606285
Hum Mutat. 2016 Nov;37(11):1162-1179
pubmed: 27435373
Clin Genet. 2018 Jul;94(1):61-69
pubmed: 29286535
BMC Cancer. 2017 Sep 5;17(1):623
pubmed: 28874130
Int J Cancer. 2018 Dec 1;143(11):2800-2813
pubmed: 29987844
J Natl Compr Canc Netw. 2017 Dec;15(12):1465-1475
pubmed: 29223984
Cancer Med. 2017 Dec;6(12):3014-3024
pubmed: 29055968
Rev Med Chil. 2006 Oct;134(10):1221-9
pubmed: 17186090
Hered Cancer Clin Pract. 2013 Dec 18;11(1):18
pubmed: 24344984
Anticancer Res. 2012 Oct;32(10):4347-51
pubmed: 23060557
J Clin Oncol. 2017 Apr 1;35(10):1086-1095
pubmed: 28135145
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Ann Oncol. 2017 Sep 1;28(9):2286-2297
pubmed: 28911064
BMJ. 2017 Jan 13;356:i6673
pubmed: 28087510
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
Genet Mol Res. 2006 Jun 30;5(2):315-22
pubmed: 16819711
CA Cancer J Clin. 2018 May;68(3):217-231
pubmed: 29485237
Gut. 2017 Sep;66(9):1657-1664
pubmed: 27261338
PLoS One. 2013 Sep 06;8(9):e72091
pubmed: 24039736
Fam Cancer. 2018 Jul;17(3):395-402
pubmed: 29128931
Salud Publica Mex. 2016 Apr;58(2):104-17
pubmed: 27557369
Hum Mutat. 2011 Apr;32(4):407-14
pubmed: 21309036
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
JAMA Oncol. 2017 Apr 1;3(4):464-471
pubmed: 27978560
Gastroenterology. 2017 Jul;153(1):307-323
pubmed: 28600072
J Med Genet. 2010 Sep;47(9):579-85
pubmed: 20587412
BMC Cancer. 2012 Feb 09;12:64
pubmed: 22321913
BMC Med Genet. 2018 Feb 20;19(1):26
pubmed: 29458332
Biomedica. 2005 Sep;25(3):315-24
pubmed: 16276679
Fam Cancer. 2010 Jun;9(2):109-15
pubmed: 19763885

Auteurs

Carlos Alberto Vaccaro (CA)

PROCANHE- Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)-CONICET, Instituto Universitario del Hospital Italiano (IUHI), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Francisco López-Kostner (F)

Laboratorio de Oncología y Genética Molecular, Clínica Los Condes, Santiago, Chile.

Della Valle Adriana (DV)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Edenir Inez Palmero (EI)

Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil & Barretos School of Health Sciences - FACISB, Barretos, SP, Brazil.

Benedito Mauro Rossi (BM)

Hospital Sirio Libanes, São Paulo, Brazil.

Marina Antelo (M)

Oncology Section of the Public Hospital of Gastroenterology "Dr. C. B. Udaondo", Buenos Aires, Argentina.
Instituto de Salud Colectiva, Universidad Nacional de Lanús, Buenos Aires, Argentina.

Angela Solano (A)

Sección de Genotipificación, Departamento de Análisis Clínicos, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.

Dirce Maria Carraro (DM)

AC Camargo Cancer Center, Sao Paulo, Brazil.

Nora Manoukian Forones (NM)

Gastroenterology Division, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Mabel Bohorquez (M)

Grupo de Investigación Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y de Ciencias de Salud, Universidad del Tolima, Ibagué, Colombia.

Leonardo S Lino-Silva (LS)

Departamento de Patologia, Instituto Nacional de Cancerologia, Mexico City, Mexico.

Jose Buleje (J)

Centro de Genética y Biología Molecular, Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martín de Porres, Lima, Perú.

Florencia Spirandelli (F)

Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina.

Kiyoko Abe-Sandes (K)

Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, Brazil.

Ivana Nascimento (I)

Instituto de Ciência da Saúde e Núcleo de Oncologia da Bahia, Salvador, Brazil.

Yasser Sullcahuaman (Y)

Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
Instituto de Investigación Genomica, Lima, Peru.

Carlos Sarroca (C)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Maria Laura Gonzalez (ML)

PROCANHE- Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)-CONICET, Instituto Universitario del Hospital Italiano (IUHI), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Alberto Ignacio Herrando (AI)

PROCANHE- Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)-CONICET, Instituto Universitario del Hospital Italiano (IUHI), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Karin Alvarez (K)

Laboratorio de Oncología y Genética Molecular, Clínica Los Condes, Santiago, Chile.

Florencia Neffa (F)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Henrique Camposreis Galvão (HC)

Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil & Barretos School of Health Sciences - FACISB, Barretos, SP, Brazil.

Patricia Esperon (P)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Mariano Golubicki (M)

Molecular Laboratory, Hospital of Gastroenterology "Dr. C. B. Udaondo", Buenos Aires, Argentina.

Daniel Cisterna (D)

Molecular Laboratory, Hospital of Gastroenterology "Dr. C. B. Udaondo", Buenos Aires, Argentina.

Florencia C Cardoso (FC)

Sección de Genotipificación, Departamento de Análisis Clínicos, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.

Giovana Tardin Torrezan (GT)

AC Camargo Cancer Center, Sao Paulo, Brazil.

Samuel Aguiar Junior (SA)

AC Camargo Cancer Center, Sao Paulo, Brazil.

Célia Aparecida Marques Pimenta (CAM)

Gastroenterology Division, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Maria Nirvana da Cruz Formiga (MN)

AC Camargo Cancer Center, Sao Paulo, Brazil.

Erika Santos (E)

Hospital Sirio Libanes, São Paulo, Brazil.

Caroline U Sá (CU)

Hospital Sirio Libanes, São Paulo, Brazil.

Edite P Oliveira (EP)

Hospital Sirio Libanes, São Paulo, Brazil.

Ricardo Fujita (R)

Centro de Genética y Biología Molecular, Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martín de Porres, Lima, Perú.

Enrique Spirandelli (E)

Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina.

Geiner Jimenez (G)

Hospital Dr. Rafael Angel Calderón Guardia, Caja Costarricense de Seguro Social, San Jose, Costa Rica.

Rodrigo Santa Cruz Guindalini (RSC)

Faculdade de Medicina-Universidade de São Paulo and Clínica de Oncologia/grupo (CLION), Clínica de Assistência à Mulher (CAM), Bahia, Brazil.

Larissa Souza Mario Bueno (LSM)

Complexo Hospital Universitário Professor Edgar Santos, Universidade Federal da Bahia, Bahia, Brazil.

Sonia Tereza Dos Santos Nogueira (ST)

ONCOCLIN (Clínica Oncológica), Manaus, Brazil.

Mariela Torres Loarte (MT)

Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
Instituto de Investigación Genomica, Lima, Peru.

Jorge Padron (J)

Fundación Santa Fé de Bogotá, Bogota, Colombia.

Maria Del Carmen Castro-Mujica (M)

Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Julio Sanchez Del Monte (JS)

Instituto Nacional de Cancerologia de México, México City, México.

Carmelo Caballero (C)

Genpath, Asunción, Paraguay.

Carlos Mario Muñeton Peña (CMM)

Unidad de Genética Médica, Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Joseph Pinto (J)

Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Lima, Peru.

Claudia Barletta-Carrillo (C)

Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Gutiérrez Angulo Melva (GA)

Centro Universitario de los Altos, Universidad de Guadalajara, Jalisco, México.

Tamara Piñero (T)

PROCANHE- Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)-CONICET, Instituto Universitario del Hospital Italiano (IUHI), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
IMTIB-Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Paola Montenegro Beltran (PM)

Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Patricia Ashton-Prolla (P)

Departamento de Genética da Universidade Federal do Rio Grande do Sul (UFRGS) e Serviço de Genética Médica do Hospital de Clinicas de Porto Alegre (HCPA) & Rede Brasileira de Câncer Hereditário, Porto Alegre, Brazil.

Yenni Rodriguez (Y)

Clinica del Country, Bogota, Colombia.

Richard Quispe (R)

Laboratorio de Genética Molecular del Instituto de Servicios de Laboratorio de Diagnóstico e Investigación en Salud (SELADIS), La Paz, Bolivia.

Norma Teresa Rossi (NT)

Hospital Privado Universitario de Cordoba, Cordoba, Argentina.

Claudia Martin (C)

Hospital Privado Universitario de Cordoba, Cordoba, Argentina.

Sergio Chialina (S)

Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina.

Pablo German Kalfayan (PG)

PROCANHE- Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)-CONICET, Instituto Universitario del Hospital Italiano (IUHI), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Juan Carlos Bazo-Alvarez (JC)

Research Department of Primary Care and Population Health, University College London, London, United Kingdom.
Centro de Estudios de Población, Universidad Católica los Ángeles de Chimbote (ULADECH-Católica), Chimbote, Perú.

Alcides Recalde Cañete (AR)

Facultad de Ciencias Medicas Médicas, Universidad Nacional de Asunción, Asuncion, Paraguay.

Constantino Dominguez-Barrera (C)

Facultad de Enfermeria, Universidad Particular Ricardo Palma, Lima, Peru.

Lina Nuñez (L)

National Institute of Cancer, Buenos Aires, Argentina.

Sabrina Daniela Da Silva (SD)

Lady Davis Institute for Medical Research and Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada.
Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, QC, Canada.

Yesilda Balavarca (Y)

Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany.

Patrik Wernhoff (P)

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

John-Paul Plazzer (JP)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Department of Medicine, Melbourne University, Melbourne, Australia.

Pål Møller (P)

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Department of Human Medicine, Universität Witten/Herdecke, Witten, Germany.

Eivind Hovig (E)

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Institute of Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
Department of Informatics, University of Oslo, Oslo, Norway.

Mev Dominguez-Valentin (M)

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH